Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Weisheng Chen, PhD
Founder and CEO at Leveragen
Speaker

Profile

Weisheng V. Chen, PhD, is Founder and CEO of Leveragen, where he is expanding the possibilities of antibody discovery through engineered immune systems. A molecular geneticist turned biotechnology entrepreneur, he leads the development of complementary platforms spanning single-domain, common light chain, and conventional antibodies. His vision connects the diversity of the immune system with the precision of genome engineering to create versatile molecular building blocks for next-generation medicines. Before founding Leveragen, Dr. Chen was a Founding Scientist and Head of Genetic Models at Kallyope. He earned his PhD at the University of Michigan and conducted postdoctoral research with Tom Maniatis at Harvard University and Columbia University.

Agenda Sessions

  • Leveragen Antibody Cosmos: Engineering Immune Diversity for Next-Generation Biologics

    , 12:00pm